PDE5 inhibitors: in vitro and in vivo pharmacological profile

D Kouvelas, A Goulas, G Papazisis… - Current …, 2009 - ingentaconnect.com
PDE5 inhibitors have been clearly established as first-line therapy for the treatment of
erectile dysfunction (ED). Three PDE5 inhibitors-sildenafil (Viagra®), vardenafil (Levitra®) …
被引用次数：75 相关文章

[引用][C] PDE5 Inhibitors: In Vitro and In Vivo Pharmacological Profile: Phosphodieterase-5 Inhibitors and their Use in the Treatment of Urological Conditions

D KOUVELAS, A GOULAS… - Current …, 2009 - pascal-francis.inist.fr
PDE5 Inhibitors: In Vitro and In Vivo Pharmacological Profile : Phosphodieterase-5
Inhibitors and their Use in the Treatment of Urological Conditions CNRS Inist Pascal-Francis …

PDE5 inhibitors: in vitro and in vivo pharmacological profile

D Kouvelas, A Goulas, G Papazisis… - Current …, 2009 - pubmed.ncbi.nlm.nih.gov
PDE5 inhibitors have been clearly established as first-line therapy for the treatment of
erectile dysfunction (ED). Three PDE5 inhibitors--sildenafil (Viagra), vardenafil (Levitra) and …
[PDF] researchgate.net

[PDF][PDF] PDE5 Inhibitors: In Vitro and In Vivo Pharmacological Profile

D Kouvelas, A Goulas, G Papazisis… - Current …, 2009 - researchgate.net
PDE5 inhibitors have been clearly established as first-line therapy for the treatment of
erectile dysfunction (ED). Three PDE5 inhibitors–sildenafil (Viagra®), vardenafil (Levitra®) …

PDE5 inhibitors: in vitro and in vivo pharmacological profile.

D Kouvelas, A Goulas, G Papazisis… - Current …, 2009 - europepmc.org
PDE5 inhibitors have been clearly established as first-line therapy for the treatment of
erectile dysfunction (ED). Three PDE5 inhibitors--sildenafil (Viagra), vardenafil (Levitra) and …

[引用][C] PDE5 Inhibitors: In Vitro and In Vivo Pharmacological Profile

D KOUVELAS, A GOULAS, G PAPAZISIS… - Current pharmaceutical …, 2009 - Bentham